ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders

S. S C Rao, M. A. Benninga, Adil Eddie Bharucha, G. Chiarioni, C. Di Lorenzo, W. E. Whitehead

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Background: Anorectal disorders such as dyssynergic defecation, fecal incontinence, levator ani syndrome, and solitary rectal ulcer syndrome are common, and affect both the adult and pediatric populations. Although they are treated with several treatment approaches, over the last two decades, biofeedback therapy using visual and verbal feedback techniques has emerged as an useful option. Because it is safe, it is commonly recommended. However, the clinical efficacy of biofeedback therapy in adults and children is not clearly known, and there is a lack of critical appraisal of the techniques used and the outcomes of biofeedback therapy for these disorders. Purpose: The American Neurogastroenterology and Motility Society and the European Society of Neurogastroenterology and Motility convened a task force to examine the indications, study performance characteristics, methodologies used, and the efficacy of biofeedback therapy, and to provide evidence-based recommendations. Based on the strength of evidence, biofeedback therapy is recommended for the short-term and long-term treatment of constipation with dyssynergic defecation (Level I, Grade A), and for the treatment of fecal incontinence (Level II, Grade B). Biofeedback therapy may be useful in the short-term treatment of Levator Ani Syndrome with dyssynergic defecation (Level II, Grade B), and solitary rectal ulcer syndrome with dyssynergic defecation (Level III, Grade C), but the evidence is fair. Evidence does not support the use of biofeedback for the treatment of childhood constipation (Level 1, Grade D).

Original languageEnglish (US)
Pages (from-to)594-609
Number of pages16
JournalNeurogastroenterology and Motility
Volume27
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Rectal Diseases
Consensus
Guidelines
Defecation
Therapeutics
Fecal Incontinence
Constipation
Ulcer
1-azidonaphthalene-5-sulfonate
Biofeedback (Psychology)
Sensory Feedback
Advisory Committees

Keywords

  • Biofeedback therapy
  • Constipation
  • Dyssynergic defecation
  • Fecal incontinence
  • Levator ani syndrome

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Gastroenterology
  • Physiology

Cite this

ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. / Rao, S. S C; Benninga, M. A.; Bharucha, Adil Eddie; Chiarioni, G.; Di Lorenzo, C.; Whitehead, W. E.

In: Neurogastroenterology and Motility, Vol. 27, No. 5, 01.05.2015, p. 594-609.

Research output: Contribution to journalArticle

Rao, S. S C ; Benninga, M. A. ; Bharucha, Adil Eddie ; Chiarioni, G. ; Di Lorenzo, C. ; Whitehead, W. E. / ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. In: Neurogastroenterology and Motility. 2015 ; Vol. 27, No. 5. pp. 594-609.
@article{4882cd38eaec44e2a9678d3bed9d6be0,
title = "ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders",
abstract = "Background: Anorectal disorders such as dyssynergic defecation, fecal incontinence, levator ani syndrome, and solitary rectal ulcer syndrome are common, and affect both the adult and pediatric populations. Although they are treated with several treatment approaches, over the last two decades, biofeedback therapy using visual and verbal feedback techniques has emerged as an useful option. Because it is safe, it is commonly recommended. However, the clinical efficacy of biofeedback therapy in adults and children is not clearly known, and there is a lack of critical appraisal of the techniques used and the outcomes of biofeedback therapy for these disorders. Purpose: The American Neurogastroenterology and Motility Society and the European Society of Neurogastroenterology and Motility convened a task force to examine the indications, study performance characteristics, methodologies used, and the efficacy of biofeedback therapy, and to provide evidence-based recommendations. Based on the strength of evidence, biofeedback therapy is recommended for the short-term and long-term treatment of constipation with dyssynergic defecation (Level I, Grade A), and for the treatment of fecal incontinence (Level II, Grade B). Biofeedback therapy may be useful in the short-term treatment of Levator Ani Syndrome with dyssynergic defecation (Level II, Grade B), and solitary rectal ulcer syndrome with dyssynergic defecation (Level III, Grade C), but the evidence is fair. Evidence does not support the use of biofeedback for the treatment of childhood constipation (Level 1, Grade D).",
keywords = "Biofeedback therapy, Constipation, Dyssynergic defecation, Fecal incontinence, Levator ani syndrome",
author = "Rao, {S. S C} and Benninga, {M. A.} and Bharucha, {Adil Eddie} and G. Chiarioni and {Di Lorenzo}, C. and Whitehead, {W. E.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1111/nmo.12520",
language = "English (US)",
volume = "27",
pages = "594--609",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders

AU - Rao, S. S C

AU - Benninga, M. A.

AU - Bharucha, Adil Eddie

AU - Chiarioni, G.

AU - Di Lorenzo, C.

AU - Whitehead, W. E.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Background: Anorectal disorders such as dyssynergic defecation, fecal incontinence, levator ani syndrome, and solitary rectal ulcer syndrome are common, and affect both the adult and pediatric populations. Although they are treated with several treatment approaches, over the last two decades, biofeedback therapy using visual and verbal feedback techniques has emerged as an useful option. Because it is safe, it is commonly recommended. However, the clinical efficacy of biofeedback therapy in adults and children is not clearly known, and there is a lack of critical appraisal of the techniques used and the outcomes of biofeedback therapy for these disorders. Purpose: The American Neurogastroenterology and Motility Society and the European Society of Neurogastroenterology and Motility convened a task force to examine the indications, study performance characteristics, methodologies used, and the efficacy of biofeedback therapy, and to provide evidence-based recommendations. Based on the strength of evidence, biofeedback therapy is recommended for the short-term and long-term treatment of constipation with dyssynergic defecation (Level I, Grade A), and for the treatment of fecal incontinence (Level II, Grade B). Biofeedback therapy may be useful in the short-term treatment of Levator Ani Syndrome with dyssynergic defecation (Level II, Grade B), and solitary rectal ulcer syndrome with dyssynergic defecation (Level III, Grade C), but the evidence is fair. Evidence does not support the use of biofeedback for the treatment of childhood constipation (Level 1, Grade D).

AB - Background: Anorectal disorders such as dyssynergic defecation, fecal incontinence, levator ani syndrome, and solitary rectal ulcer syndrome are common, and affect both the adult and pediatric populations. Although they are treated with several treatment approaches, over the last two decades, biofeedback therapy using visual and verbal feedback techniques has emerged as an useful option. Because it is safe, it is commonly recommended. However, the clinical efficacy of biofeedback therapy in adults and children is not clearly known, and there is a lack of critical appraisal of the techniques used and the outcomes of biofeedback therapy for these disorders. Purpose: The American Neurogastroenterology and Motility Society and the European Society of Neurogastroenterology and Motility convened a task force to examine the indications, study performance characteristics, methodologies used, and the efficacy of biofeedback therapy, and to provide evidence-based recommendations. Based on the strength of evidence, biofeedback therapy is recommended for the short-term and long-term treatment of constipation with dyssynergic defecation (Level I, Grade A), and for the treatment of fecal incontinence (Level II, Grade B). Biofeedback therapy may be useful in the short-term treatment of Levator Ani Syndrome with dyssynergic defecation (Level II, Grade B), and solitary rectal ulcer syndrome with dyssynergic defecation (Level III, Grade C), but the evidence is fair. Evidence does not support the use of biofeedback for the treatment of childhood constipation (Level 1, Grade D).

KW - Biofeedback therapy

KW - Constipation

KW - Dyssynergic defecation

KW - Fecal incontinence

KW - Levator ani syndrome

UR - http://www.scopus.com/inward/record.url?scp=84928207421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928207421&partnerID=8YFLogxK

U2 - 10.1111/nmo.12520

DO - 10.1111/nmo.12520

M3 - Article

C2 - 25828100

AN - SCOPUS:84928207421

VL - 27

SP - 594

EP - 609

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - 5

ER -